Postoperative management after hepatic resection

By -

 

Wrighton, L. J., O'Bosky, K. R., Namm, J. P., & Senthil, M. (2012). Postoperative management after hepatic resection. Journal of gastrointestinal oncology, 3(1), 41–47. https://doi.org/10.3978/j.issn.2078-6891.2012.003

Executive Summary

The postoperative management of patients following hepatic resection presents a unique set of clinical challenges driven by complex metabolic and functional changes in the remnant liver. While advances in surgical and anesthetic techniques have significantly improved outcomes, optimizing patient recovery requires a deep understanding of hepatic physiology and a customized, multi-faceted management plan. This document synthesizes the critical issues and evidence-based strategies for post-hepatectomy care.

Key takeaways from the analysis include:

  • Paradoxical Coagulation State: Despite potential elevations in standard coagulation markers like INR, patients are in a prothrombotic, hypercoagulable state due to a disproportionate decrease in natural anticoagulants. Pharmacologic thromboprophylaxis is therefore recommended starting on the day of surgery to reduce venous thromboembolism (VTE) risk.

  • Superiority of Enteral Nutrition: Early enteral feeding is firmly established as superior to parenteral nutrition, significantly reducing infectious complications and improving postoperative immune competence. Supplementation with branched-chain amino acids (BCAAs) shows considerable promise for improving nutritional status and quality of life, particularly in patients with chronic liver disease.

  • Metabolic Instability Management: Postoperative hyperglycemia, hyperlactemia, and hypophosphatemia are common and consequential. Strict glycemic control is crucial but challenging due to insulin resistance. Hypophosphatemia occurs in nearly all patients after major resection and can lead to severe cellular dysfunction; it requires aggressive replacement, though optimal monitoring and replacement methods are still being defined.

  • Emerging Infection Prevention: Synbiotic therapy—the combination of pro- and prebiotics—has emerged as a simple and safe intervention that significantly reduces postoperative infectious complications by improving intestinal microbial balance and protecting gut barrier function.

  • Multimodal Pain Control: A tailored, multimodal approach to pain management is essential. While opioids are a mainstay, their metabolism is impaired post-resection, necessitating careful monitoring. Epidural anesthesia is effective but carries a risk of hematoma due to coagulopathy, making alternatives like local anesthetic infusions and single-dose intrathecal morphine valuable components of the pain control strategy.

Detailed Analysis of Postoperative Management Themes

1. Fluid and Electrolyte Derangements

The immediate postoperative period is characterized by significant fluid and electrolyte imbalances that require vigilant management.

  • Fluid Balance: Patients with cirrhosis are particularly prone to fluid shifts, vasodilation, and subsequent hypotension. In these cases, colloids are recommended over crystalloids to restore intravascular volume. New-onset postoperative ascites is common in cirrhotic patients and is managed with sodium restriction and judicious use of diuretics, with paracentesis reserved for tense ascites.

  • Hyperlactemia: The liver normally consumes 40-60% of lactate via gluconeogenesis, but a damaged or stressed liver produces lactate instead.

    • Clinical Significance: A study by Watanabe et al. found that initial arterial plasma lactate concentration was significantly higher in non-survivors than survivors and served as an excellent independent predictor of morbidity and mortality.

    • Management: To avoid exacerbating this condition, non-lactate-containing intravenous solutions are recommended for postoperative fluid administration.

  • Hypophosphatemia: This condition is encountered in nearly all patients following a major hepatic resection and can have severe consequences.

    • Pathogenesis: The cause is poorly understood and is theorized to be either from increased phosphate uptake by regenerating hepatocytes or, as suggested by recent research, from excessive urinary losses mediated by "phosphatonins."

    • Consequences: Hypophosphatemia impairs energy metabolism, leading to cellular dysfunction across multiple organ systems, including respiratory failure, cardiac arrhythmias, hematologic dysfunction, and insulin resistance.

    • Management and Monitoring: Standard care involves phosphate replacement guided by serum levels. However, serum measurements may be inaccurate due to intra-extracellular shifts. More sensitive physiological markers, such as serum 2,3-diphosphoglycerol (2,3-DPG) and urinary nucleotide breakdown products, have been proposed but require further validation.

2. Nutritional Support Strategies

The post-hepatectomy period is a catabolic state where nutritional support is paramount for hepatic regeneration and overall recovery.

  • Enteral vs. Parenteral Nutrition: The evidence strongly favors the use of early enteral nutrition.

    • A systematic review of five randomized controlled studies concluded that enteral nutrition resulted in a significantly lower rate of wound infections and catheter-related complications compared to parenteral nutrition.

    • Patients receiving enteral nutrition also demonstrated better postoperative immune competence.

    • Conversely, one study by Hotta et al. found that supplementation with Total Parenteral Nutrition (TPN) had no effect on postoperative outcomes.

  • Specialized Nutrients: Branched-Chain Amino Acids (BCAA): BCAA (leucine, isoleucine, valine) supplementation has shown significant benefits, especially for patients with underlying liver disease.

    • Rationale: Liver disease alters amino acid metabolism, leading to low circulating BCAA levels.

    • Evidence:

      • In patients with advanced cirrhosis, BCAA supplementation improved nutritional status and decreased complication frequency.

      • A study by Okabayashi et al. found that oral supplementation with BCAAs and carbohydrates led to steadily improving quality-of-life measures up to 12 months post-hepatectomy.

      • Animal studies show BCAAs promote liver regeneration.

      • Another study suggested BCAA supplementation may protect liver cells from ischemic injury by increasing serum erythropoietin levels.

3. Glycemic Control

Surgical stress induces hyperglycemia, which adversely affects liver metabolism and immune function. Strict glycemic control is important but challenging after liver resection due to insulin resistance.

  • Impact of Hyperglycemia: Has been shown to be a risk factor for adverse postoperative outcomes, including hepatic decompensation and increased perioperative mortality.

  • Interventions for Tight Control:

    • Closed-Loop Insulin Administration: A study of an artificial pancreas system found it to be safe and effective, though the mean blood glucose level remained above the target range of 90-110 mg/dl.

    • Hyperinsulinemic-Normoglycemic Clamp: This technique, combined with a preoperative carbohydrate load, was found by Fisette et al. to reduce postoperative liver dysfunction, infections, and complications when compared to a standard insulin sliding scale.

    • Institutional Approach: Achieving optimal glycemic control requires a standardized, multi-team approach within the institution.

4. Coagulopathy and Thromboprophylaxis

Derangements in coagulation are common post-hepatectomy and present a complex management challenge involving both bleeding and clotting risks.

Coagulopathy

  • Postoperative Profile: Patients typically exhibit an increase in Prothrombin Time/INR (PT/INR) and a decrease in platelet count and fibrinogen. This coagulopathy peaks between postoperative days 2 and 5 due to the remnant liver's decreased synthetic function and the consumption of clotting factors.

  • Management of Elevated INR:

    • The prolongation of PT/INR is often self-limited in non-cirrhotic patients.

    • There is no consensus on the criteria for prophylactic administration of fresh frozen plasma (FFP). One center reported prophylactic use for a PT >16 seconds with a low (0.4%) reoperation rate for bleeding, while other centers use an INR threshold above 2.0.

    • For high-risk cirrhotic patients, a combination of FFP, vitamin K, octreotide, and recombinant factor VIIa may be used.

Thromboprophylaxis

  • Hypercoagulable State: Despite elevated INR, hepatectomy patients are in a hypercoagulable state. This paradox is explained by several factors:

    • Synthesis of anticoagulants (protein C, S, and antithrombin) decreases by more than 50%.

    • Levels of procoagulants von Willebrand factor and factor VIII are increased, likely due to surgical trauma.

    • This prothrombotic state persists to postoperative day five, even after INR values have normalized.

  • Recommendations: The prevalence of postoperative venous thromboembolism (VTE) in general surgery is 15-40%.

    • A retrospective review of 415 major hepatectomy patients demonstrated that administering pharmacologic thromboprophylaxis lowered the rate of VTE without increasing the rate of red blood cell transfusion.

    • Pharmacologic thromboprophylaxis should be administered starting the day of surgery unless a high risk of bleeding exists.

5. Pain Management

Optimal postoperative pain control is crucial for early mobilization and improved respiratory function. A multimodal approach tailored to the individual is recommended.

  • Opioids: Morphine, hydromorphone, and fentanyl are the mainstays of pain control.

    • Risks: Side effects include sedation, respiratory depression, and exacerbation of hepatic encephalopathy.

    • Metabolism: Larger volume resections result in greater impairment of opioid metabolism, leading to drug accumulation and increased bioavailability, especially in cirrhotic patients. Hydromorphone and fentanyl are less affected by renal impairment and serve as better alternatives in patients with renal dysfunction.

  • Epidural Anesthesia: While effective for reducing pulmonary complications and providing superior pain control, its use is complicated by postoperative coagulopathy.

    • The peak of coagulopathy (days 2-5) coincides with the recommended time for epidural catheter removal, increasing the risk of epidural hematoma.

    • A single intrathecal injection of morphine combined with postoperative patient-controlled analgesia (PCA) has been reported as an effective alternative.

  • Adjunctive and Local Therapies:

    • Intravenous Acetaminophen: Recently available in the U.S., with a recommended maximum dose of 2g/day in patients with hepatic impairment.

    • NSAIDs: Generally not recommended due to risks of bleeding and hepatorenal syndrome.

    • Local Anesthetic Infusion: The On-Q Pain Buster system, placed in the subcostal wound, has been shown to decrease total morphine consumption and improve pain control when combined with PCA.

6. Postoperative Infection

Infection is a major contributor to postoperative morbidity and mortality. Prevention and early, aggressive treatment are critical.

  • Risk Factors: Key predictors of infectious complications include obesity, preoperative biliary drainage, extent of resection, operative blood loss, and postoperative bile leak.

  • Standard Measures: Early mobilization, proper catheter care, and aggressive pulmonary toilet are routine preventive measures. Prompt institution of broad-spectrum antibiotics and source control are vital once an infection is suspected.

  • Synbiotic Treatment: This has emerged as a promising preventive strategy based on the concept of gut-mediated systemic inflammation.

    • Definition: Synbiotics are a combination of probiotics (viable beneficial bacteria) and prebiotics (non-digestive food constituents that promote their growth).

    • Mechanism: They improve intestinal microbial balance and protect gut barrier function.

    • Evidence:

      • A study by Usami et al. found that perioperative synbiotic treatment reduced the rate of infectious complications from 17.2% in the control group to 0%.

      • Another study by Sugawara et al. reported a reduction in infectious complications from 30% to 12.1% with perioperative synbiotics.